nitroblue tetrazolium has been researched along with chelerythrine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstead, WM | 1 |
1 other study(ies) available for nitroblue tetrazolium and chelerythrine
Article | Year |
---|---|
NOC/oFQ PKC-dependent superoxide generation contributes to hypoxic-ischemic impairment of NMDA cerebrovasodilation.
Topics: Alkaloids; Animals; Animals, Newborn; Anions; Benzophenanthridines; Cerebral Arteries; Cerebrovascular Circulation; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Female; Free Radicals; Hypoxia-Ischemia, Brain; Indicators and Reagents; Male; N-Methylaspartate; Nitroblue Tetrazolium; Nociceptin; Opioid Peptides; Peptide Fragments; Phenanthridines; Pia Mater; Protein Kinase C; Staurosporine; Superoxide Dismutase; Superoxides; Swine; Vasodilation; Vasodilator Agents | 2000 |